Skip to main content
PMC home page
Cell Death & Disease logoLink to Cell Death & Disease
. 2015 Feb 19;6(2):e1654. doi: 10.1038/cddis.2015.32

Annexin-1 regulated by HAUSP is essential for UV-induced damage response

J-J Park 1,2, K-H Lim 1,2, K-H Baek 1,*
PMCID: PMC4669820  PMID: 25695607

Abstract

DNA damage can occur through diverse stimulations such as toxins, drugs, and environmental factors. To respond to DNA damage, mammalian cells induce DNA damage response (DDR). DDR signal activates a rapid signal transduction pathway, regulating the cell fate based on the damaged cell condition. Moreover, serious damaged cells have to be eliminated by the macrophage to maintain homeostasis. Because the DDR induces genomic instability followed by tumor formation, targeting the DDR signaling can be applied for the cancer therapy. Herpes virus-associated ubiquitin-specific protease (HAUSP/USP7) is one of the well-known deubiquitinating enzymes (DUBs) owing to its relevance with Mdm2-p53 complex. The involvement of HAUSP in DDR through p53 led us to investigate novel substrates for HAUSP, which is related to DDR or apoptosis. As a result, we identified annexin-1 (ANXA1) as one of the putative substrates for HAUSP. ANXA1 has numerous roles in cellular systems including anti-inflammation, damage response, and apoptosis. Several studies have demonstrated that ANXA1 can be modified in a post-translational manner by processes such as phosphorylation, SUMOylation, and ubiquitination. In addition, DNA damage gives various functions to ANXA1 such as stress response or cleavage-mediated apoptotic cell clearance. In the current study, our proteomic analysis using two-dimensional electrophoresis, matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry (MALDI-TOF-MS) and nano LC-MS/MS, and immunoprecipitation revealed that ANXA1 binds to HAUSP through its HAUSP-binding motif (P/AXXS), and the cleavage and damage-responsive functions of ANXA1 upon UV-induced DNA damage may be followed by HAUSP-mediated deubiquitination of ANXA1. Intriguingly, the UV-induced damage responses via HAUSP-ANXA1 interaction in HeLa cells were different from the responses shown in the Jurkat cells, suggesting that their change of roles may depend on the cell types.

Most proteins follow the ubiquitin-proteasome pathway (UPP) to degradation; this involves successive enzymatic activities of the E1, E2, and E3 enzymes. In addition to proteasomal degradation, the proteins obtain or alter their functions through mono- or polyubiquitination.1 Thus, the ‘ubiquitin tag' is considered as an important feature for intracellular homeostasis. Deubiquitination is a reversible process against ubiquitination that detaches ubiquitin molecules from ubiquitinated proteins, and the process of deubiquitination is mediated by specific enzymes called deubiquitinating enzymes (DUBs). To date, almost ~100 DUBs have been identified, and they are involved in various cellular functions through their capability by which they deubiquitinate and thereby stabilize or alter the functions of their target proteins.2 DUBs are composed of at least six subfamilies: ubiquitin-specific proteases (USPs), ubiquitin C-terminal hydrolases (UCHs), ovarian tumor (OTU), Machado-Josephin domain papain-like cysteine proteases (MJDs), JAB1/MPN/Mov34 metalloenzyme (JAMM) domain zinc-dependent metalloprotease family, and monocyte chemotactic protein-induced proteases (MCPIPs).3 In addition, DUBs share specific regions including Cys, Asp/Asn, and His boxes for their deubiquitinating activities.4 The USP family has the most number among DUBs (~58 USPs),5 and many studies have demonstrated that human USPs have important roles in a broad range of cellular systems.6 In particular, their involvement in cell proliferation, signal transduction, and apoptosis emphasizes that abnormal or deregulated functions of USPs can be related to severe diseases including immune disorders and cancers.2, 6, 7 Accordingly, USPs have been widely targeted for the therapy of several diseases; however, a clear understanding of the molecular details underlining USPs and other DUBs has not yet been obtained.

HAUSP, also known as USP7, is a member of the USP family of DUBs. The importance of HAUSP in cells was demonstrated by its ability to specifically recognize and deubiquitinate both the tumor suppressor p53 and Mdm2, a p53-specific E3 ligase. In the normal state, HAUSP specifically binds to and deubiquitinates Mdm2, thereby stabilizing Mdm2 and subsequently inducing the proteasomal degradation of p53 through Mdm2 activity. Upon DNA damage, HAUSP is dephosphorylated by PPM1G. In this state, the deubiquitinating activity of HAUSP for Mdm2 decreases and HAUSP prefers p53 for its substrate instead of Mdm2. Such altered affinity of HAUSP to p53 leads to DNA repair and tumor-suppressive functions of p53.8, 9, 10 In addition to Mdm2 and p53, further studies have revealed that HAUSP can regulate various substrates, including ataxin-1, Chfr, claspin, Daxx, FOXO4, histone H2B, PTEN, NF-κB, Tip60, UbE2E1, and UVSSA.2 These findings suggest that HAUSP has diverse roles in the cell through the regulation of different substrates and other additional proteins. In a present study, we performed two-dimensional gel electrophoresis (2-DE) and other proteomics-based experiments using HeLa cells to identify putative substrates regulated by HAUSP. We found several putative substrates, some of which are known to be involved in apoptosis or DNA damage response (DDR). Annexin a1, also known as ANXA1 and lipocortin 1, was also found as a putative binding partner for HAUSP, suggesting that ANXA1 may possibly be regulated by HAUSP-mediated deubiquitination.

Annexins consist of 13 annexin members and have four conserved repeated domains, which are responsible for Ca2+ and phospholipid binding. In most annexins, the conserved annexin domains enable them to bind the phospholipid of the membranes in a Ca2+-dependent manner, resulting in subsequent activities such as membrane trafficking, signal transduction, and exocytosis.11 However, major differences of annexins derive from their unique N-terminal regions. The N-terminus of each annexin member, which is responsible for specific functions, varies.12 ANXA1, the first member of the annexin superfamily, is a 37-kDa protein abundant in cells. Like other annexin proteins, ANXA1 binds to phospholipid in the presence of Ca2+.13 The biological functions of ANXA1 are extensively studied: anti-inflammatory mediator,14, 15 relationship with tumorigenesis,16 DDR,17, 18 and involvement in apoptosis and apoptotic cell clearance.19, 20 Another important feature of ANXA1 activity is the cleavage of the N-terminal region of ANXA1. When DNA damage or stress occurs, ANXA1 is cleaved by several proteases, resulting in the generation of the N-terminal fragment (Ac2-26) and cleaved form of ANXA1 (33 kDa). Importantly, both the full-length ANXA1 and Ac2-26 can be translocated to the cell membrane and induce apoptotic cell clearance by recruiting monocytes via chemoattraction.20 Thus, the ANXA1 cleavage process is considered essential for cell phagocytosis, as also revealed in neutrophil apoptosis and phagocytosis during inflammation.14 Otherwise, in response to cell damage, ANXA1 functions as a stress protein or a protective protein for DNA damage, resulting in nuclear localization of ANXA1.18, 21, 22 Overall, it is evident that ANXA1 participates in various cellular responses.

In the current study, we have identified ANXA1 as a novel substrate for HAUSP. HAUSP can bind to, deubiquitinate, and co-localize with ANXA1. Surprisingly, upon UV-induced DNA damage, the binding and the deubiquitinating activity of HAUSP to ANXA1 are increased. In addition, ANXA1 in HAUSP-deficient cells showed different localization and altered expression level and cleavage. Moreover, HAUSP-mediated regulation of ANXA1 shown in HeLa cells was different from the one in Jurkat cells. We found that apoptosis and transmigrative ratio of monocytes in HAUSP-depleted Jurkat cells coincides with the regulation of ANXA1 protein level and cleavage. Taken together, we suggest that ANXA1 functions of UV-induced DDR are regulated by the deubiquitinating activity of HAUSP.

Results

Identification of apoptosis-regulating proteins in HAUSP-overexpressing cells

A previous study showed that the HAUSP overexpression regulates cancer cell proliferation and apoptosis through p53 signaling. 9 We also found previously that the overexpression of HAUSP leads to cancer cell apoptosis.23, 24 We explored the mechanisms involved in HAUSP-related cancer cell regulation by performing 2-DE-SDS-PAGE analysis using HAUSP-overexpressing cells (Figure 1a; Supplementary Figure S1). A total of 2095 protein spots were detected by Coomassie Brilliant Blue (CBB) G-250 (pH ranges 3–10) (Figure 1b). Comparative analysis between the control and HAUSP-overexpressing cells was conducted using a 2-DE gel image analysis program (Amersham, ImageMaster 2D Platinum, Piscataway, NJ, USA). We then determined a total of 16 upregulated proteins in the HAUSP-overexpressing cell lysate that showed 2- to 10-fold increases. Proteins were identified by tandem mass spectrometric analysis, and we assessed the identity of protein spots using the MASCOT search engine. The proteins identified based on probability-based scoring and spectra are summarized in Table 1 and Supplementary Figure S2. We used the high scores to select five proteins; nucleolin (spot ID 181), villin (spot ID 323), pyruvate kinase M2 (known as PKM2) (spot ID 550), ANXA1 (spot ID 1081), and PP2CA (known as PP2A) (spot ID 1117) (Figure 1c). We then checked the mRNA levels of these five proteins to evaluate the transcriptional regulation of the upregulated proteins (Supplementary Figure S3). Overexpression of HAUSP significantly increased villin mRNA level, but the other proteins (nucleolin, PKM2, ANXA1, and PP2A) did not show any significant change in their transcriptional levels (Supplementary Figure S3). The overexpression of HAUSP may, therefore, lead to the stabilization of nucleolin, PKM2, ANXA1, and PP2A by post-translational modification.

Figure 1.

Figure 1

Open in a new tab

Identification of HAUSP interacting proteins. (a) HeLa cells expressing Myc-tagged HAUSP and these cell extracts were immunoblotted with an anti-Myc antibody. (b) Myc-tagged empty vector (left) and HAUSP (right) were transfected into HeLa cells. For the gel image analysis, we used a vector control (left) and HAUSP overexpression (right) lysates, and analyzed by 2-DE SDS-PAGE. The arrows indicated in the right panel represent all changed proteins as presented in Table 1. (c) Five apoptosis-related proteins are indicated. The arrows indicate in the right panel represent upregulated proteins by HAUSP overexpression compared with a control (left). (d–g) Myc-tagged HAUSP and Flag-tagged nucleolin, PKM2, PP2A, and ANXA1-overexpressing HEK 293T cell extracts were immunoprecipitated with an anti-Flag antibody. Then, the immunoprecipitation and protein expression were analyzed by immunoblotting with anti-Myc and anti-Flag antibodies. For the reciprocal immunoprecipitation, Myc-tagged HAUSP and Flag-tagged nucleolin, PKM2, PP2A, and ANXA1-overexpressing cell lysates were immunoprecipitated with an anti-Myc antibody followed by immunoblotting with an anti-Flag antibody

Table 1. Protein identities determined by MALDI-TOF/MS.

Spot ID Accession number Protein name Scorea Matched peptide number Sequence coverage (%) Matching sequence Theoretical MW/pI
33 gi|31645 Glyceraldehyde-3-phosphatedehydrogenase 108 14/45 (31%) 39 LVINGNPITIFQERDPSKIKWGDAGAEYVVESTGVFTTMEK, RVIISAPSADAPMFVMGVNHEK, GALQNIIPASTGAAK, V IPELDGKLTG MAFRVPTANV SVVDLTCR, L ISWYDNEFGY SNRVVDLMAH MASK 36202/8.26
36 gi|9367836 FOG2, friend of GATA2, altenatively spliced product 71 10/124 (8%) 63 TKAQVPMVLTAGPKWLLDVTWQGVEDNKNNCIVYSKGGQLWCTTTKAISEGEELIALVVDF DSRLQAASQMTLTEGMYPAR, CSVLCSPALEVMGIYGRK 17185/9.13
181 gi|189306 Nucleolin 126 13/26 (50%) 23 TGISDVFAKNDLAVVDVR, VTQDELKEVFEDAAEIR, SKGIAYIEFK, SISLYYTGEKGQNQDYR, TLVLSNLSYSATEETLQEVFEK, SKGYAFIEFASFEDAK, AIRLELQGPR, GLSEDTTEETLKESFDGSVR, GFGFVDFNSEEDAKEAMEDGEIDGNKVTLDWAKPK 76355/4.59
255 gi|83699649 Heat-shock 90 kDa protein 1, alpha 77 16/66 (24%) 20 DRLDPRPGSPSEASSPPFLR, ELISNSSDALDKIR, HNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEER, HSQFIGYPITLFVEKER, SLTNDWEDHLAVKHFSVEGQLEFR, RAPFDLFENR, GVVDSEDLPLNISR 98082/5.07
323 gi|46249758 Villin 2 (ezrin) 76 11/25 (44%) 19 VTTMDAELEFAIQPNTTGK, LFFLQVK, DQWEDRIQVWHAEHR, IAQDLEMYGINYFEIK, FVIKPIDKKAPDFVFYAPR, SQEQLAAELAEYTAK, QLLTLSSELSQAR 69313/5.94
395 gi|5729877 Heat-shock 70 kDa protein 8 isoform 1 137 11/14 (78%) 22 TTPSYVAFTDTER, HWPFMVVNDAGRPK, TVTNAVVTVPAYFNDSQR, DAGTIAGLNVLRIINEPTAAAIAYGLDKK, MVNHFIAEFK, ARFEELNADLFR, LDKSQIHDIVLVGGS TR, QTQTFTTYSDNQPGVLIQVYEGER, NSLESYAFNMK 71082/5.37
550 gi|33870117 PKM2 protein 1 127 14/26 (53%) 29 LDIDSPPITAR, LNFSHGTHEYHAETIK, TATESFASDPILYRPVAVALDTKGPEIR, IYVDDGLISLQVK, FGVEQDVDMVFASFIR, RFDEILEASDGIMVAR, MQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFK, GHVVIVLTGWRPGSGFTNTMR 62046/8.99
552 gi|4680681 CGI-21 protein 64 10/71 (14%) 36 SSIPHWRISRMCLKPTFTK, AYDGTTYLPGIVGLNNIK, RPPGDIMFLLVQR, AHVSPHEMLQAVVLCSKK, KLPHPDLPAEEK, EQLIIPQVPLFNILAK, LPPYLIFCIKIFTKNNFFVEK 37518/9.47
605 gi|119570522 Interferon-induced protein with tetratricopeptide repeats 1, isoform CRA_b 66 12/70 (17%) 34 VLDQIEFLDTK, FRYRMECPEIDCEEGWALLKCGGK, VLEVDPENPESSAGYAISAYR, NHKPFSLLPLR, YIEEALANMSSQTYVFR, SAIFHFESAVEKKPTFEVAHLDLAR, KSDVNAIIHYLKAIKIEQASLTR, LEGNMNEALEYYE R, LAADFE NSVR 51681/8.55
608 gi|73620945 Bullous pemphigoid antigen 1, isoforms 6/9/10 (Trabeculin-beta) 73 41/81 (50%) 9 VQRDSVICEDK, NECSSVYSKGR, AIEEFESSLKEAK, ELDQKEENIK, EELLQYKSTIANLMGKTIIQLKPR, SVVSWHYLINEIDR, ISSEEISTKK, QQEYKEK, GDLRYITISGNR, LDHATDRFR, HLSEPIAVDPK, QSSINAMNEKVK, EAVTSCQEQLDAFQVLVK, AQEESSAMMQWLQK, SFEAELKQNVNK, WKQMLTEIDSK, CSFLETKLQGIGHFR, MMLATEETSPDLVGIK, LSVQDYSTEGLWKQQSELR, TLEQALQLAR, ALLDSLNEVSSALLELVPWR, LEQDQTSAQQVQKTFTMEILRHR, NYDTICQINSER, LQPLYETLK, FWCDHMSLIVTIK, QQIEELK, HHVLQNDVLAHQSTVEAVNK, WQNVLEKTEQR, SAETNIDQDINNLK, SLGAKHSVYDTTNR, DDSSWVKVQMQELSTR, ARFEEVLAWAKQELLEALLAWLQWAETTLTDK, DAYKPITDADKIEDEVTRQVAK, FQVEQIGDNKYR 590626/5.49
609 gi|5174735 Tubulin, beta, 2 121 15/65 (23%) 41 FWEVISDEHGI DPTGTYHGDSDLQLER, AVLVDLEPGTMDSVRSGPFGQIFRPDNFVFGQSGAGNNWAKGHYTEGAELVDSVLDVVRK, IMNTFSVVPSPK, FPGQLNADLRKLAVNMVPFPR, ALTVPELTQQMFDAK, YLTVAAVFR, NSSYFVEWIPNNVK, MSATFIGNSTAIQELFKRISEQFTAMFR 49799/4.79
1081 gi|4502101 Annexin I 71 13/99 (13%) 52 QAWFIENEEQEYVQTVK, GGPGSAVSPYPTFNPSSDVAALHK, GVDEATIIDILTKR, AAYLQETGKPLDETLKKALTGHLEEVVLALLKTPAQFDADELR, GLGTDEDTLIEILASR, KGTDVNVFNTILTTR, CATSKPAFFAEKLHQAMK, SEIDMNDIKAFYQKMYGISLCQAILDETKGDYEK 38690/6.57
1117 gi|48146951 PPP2CA 67 10/86 (11%) 47 EILTKESNVQEVR, SPDTNYLFMGDYVDRGYYSVETVTLLVALK, ALDRPQEVPHEGPMCDLLWSDPDDR, GAGYTFGQDISETFNHANGLTLVSRAHQLVMEGYNWCHDRNVVTIFSAPNYCYR, YSFLQFDPAPR, GEPHVTRRTPDYFL 35527/5.30
1223 gi|62897717 Lactate dehydrogenase A variant 80 11/67 (16%) 28 MATLKDQLIYNLLKEEQTPQNK, DLADELALVDVIEDKLKGEMMDLQHGSLFLR, LVIITAGAR, FIIPNVVK, EVHKQVVESAYEVIK, KSADTLWGIQK 36666/7.63
1781 gi|55957383 Zinc finger protein 618 57 19/120 (15%) 23 NQPGGAAAPQADGASAAGRK, NQQTLDGKAPEGSPHGGSVR, YASGSYECGICGKK, TQTNQSGKK, CATLLHRTPPATQTQTFRTPNSGSPASK, SPPAVVEEK, NSANNTTTSGLTPNSMIPEK, VSTSAFSKAGMCLRCSACALNSVVQSVLSK, LCHLFLEALK, VAMILDPQQK, KPRSAAVENPAAQEDDR, LAFWLLAVPAVGAR, RLLSPEDMNK 104889/6.70
2014 gi|4504301 H4 histone family, member A 110 9/26 (34%) 56 DNIQGITKPAIRR, ISGLIYEETRGVLKVFLENVIRDAVTYTEHAK, TVTAMDVVYALKR 11360/11.36
Open in a new tab
a

Score is −10 × Log(P), where P is the probability that the observed match is a random event; it is based on NCBInr database using the MASCOT searching program as MS/MS data.

ANXA1 interacts with HAUSP through its HAUSP-binding motif

We previously identified ANXA1 as one of candidates for HAUSP-binding partners (Figure 1g). Therefore, we next tested endogenous interaction between HAUSP and ANXA1. Their interaction was confirmed by endogenous immunoprecipitation (IP) in HeLa cells or in vitro biochemical assay with GST-tagged HAUSP, indicating that ANXA1 binds to HAUSP (Figures 2a and b; Supplementary Figure S4). Recently, an increasing line of evidence, namely, that substrates of HAUSP have amino-acid sequences for HAUSP-binding motifs (P/AXXS), has been reported.8 Because ANXA1 also has HAUSP-binding motif sequences (AMVS and ALLS) on its N-terminal region and annexin conserved domain (Figure 2c), we assumed that the binding of ANXA1 to HAUSP is mediated through HAUSP-binding motifs. Thus, we generated ANXA1 mutants that are mutated on its HAUSP-binding motif (S5A, S182A, and S5A/S182A) to investigate whether these motifs are important for interaction with HAUSP. ANXA1 mutants showed reduced binding affinity to HAUSP compared with wild-type ANXA1 (Figure 2d), demonstrating that HAUSP-binding motif on ANXA1 is indeed required to bind to HAUSP. Finally, the localization study by immunofluorescence analysis in HeLa cells showed that HAUSP and ANXA1 are co-localized in the nucleus (Figure 2e). Overall, our data clearly indicate that ANXA1 binds to HAUSP through its HAUSP-binding motifs and is co-localized with HAUSP in the nucleus.

Figure 2.

Figure 2

Open in a new tab

ANXA1 interacts with HAUSP via its HAUSP-binding motif. (a, b) HeLa cells were lysed, and proteins were immunoprecipitated with either an anti-HAUSP or an anti-ANXA1 antibody. Western blotting was performed using anti-HAUSP and anti-ANXA1 antibodies to detect endogenous binding between HAUSP and ANXA1. (c) Schematic of amino-acid structure of ANXA1. The amino-acid sequences showing HAUSP-binding motifs (AMVS and ALLS) are indicated in red color. (d) Myc-HAUSP and/or wild-type ANXA1, ANXA1 (S5A), ANXA1 (S182A), and ANXA1 (S5A/S182A) were transfected into HEK 293T cells. After lysis, cell lysates were immunoprecipitated with an anti-Myc antibody, and western blotting was performed using an anti-ANXA1 antibody to detect the binding affinity of ANXA1 to HAUSP. Statistical data are presented as a means (n=3, *P<0.05). (e) HeLa cells on coverglass were incubated with anti-HAUSP and anti-ANXA1 antibodies followed by FITC staining. DAPI was used for counterstaining of the nucleus (Green: ANXA1, Red: HAUSP, Blue: DAPI, Yellow: co-localization). The statistical data are representative of four biological replicates (n=4, *P<0.05)

Deubiquitinating activity of HAUSP toward ANXA1

It has been demonstrated that ANXA1 undergoes UPP;25 therefore, we hypothesize that HAUSP can protect ANXA1 from proteasomal degradation via the deubiquitinating capacity. We first reconfirmed the ubiquitination of ANXA1 (Figures 3a and c). The treatment of MG132, a proteasome inhibitor, dramatically increased ubiquitinated ANXA1. This suggests that ANXA1 may be degraded by the 26S proteasome. Next, we investigated the deubiquitinating capability of HAUSP toward ANXA1. Overexpression of HAUSP reduced the ubiquitination level of ANXA1 (Figures 3b and d). Moreover, dose-dependent overexpression of HAUSP increased the ANXA1 protein level, as confirmed by western blotting (Supplementary Figure S5). These results demonstrate that HAUSP is involved in the regulation for the ubiquitination of ANXA1.

Figure 3.

Figure 3

Open in a new tab

HAUSP deubiquitinates and stabilizes ANXA1. (a) The ubiquitination of ANXA1 was detected by immunoprecipitation with an anti-Flag antibody in Flag-ANXA1 and HA-ubiquitin transfected HEK 293T cell lysates. For inhibition of the 26S proteasome, 2.5 μM of MG132, a proteasome inhibitor, was treated for 4 h before cell harvest. (b) HEK 293T cell lysates transfected with Myc-HAUSP or Myc-HAUSP catalytic mutant (C223S), Flag-ANXA1, and HA-ubiquitin were immunoprecipitated with an anti-Flag antibody. Subsequently, western blotting was performed to detect the ubiquitination level of ANXA1. (c) Cell lysates from HEK 293T cells transfected with Flag-ANXA1 and His-ubiquitin were subjected to ubiquitination assay with Ni-NTA beads. For inhibition of the 26S proteasome, 2.5 μM of MG132 was treated for 4 h before cell harvest. Western blotting was performed with indicated antibodies. (d) Cell lysates from HEK 293T cells transfected with Myc-HAUSP or a catalytic mutant Myc-HAUSP (C223S), Flag-ANXA1, and His-ubiquitin were subjected to deubiquitination assay with Ni-NTA beads. The proteasome inhibitor MG132 was treated for 4 h before cell harvest. Western blotting was performed with indicated antibodies

Deubiquitination of ANXA1 by HAUSP regulates UV-induced damage response in HeLa cells

We further investigated the functional effect of the interaction between HAUSP and ANXA1 following DNA damage. Because a previous study showed cleavage of ANXA1 upon various DNA damage including UV,20 we first confirmed ANXA1 protein levels in response to UV with the level of PARP cleavage as an UV irradiation control. As shown in Figure 4a, the cleaved form of ANXA1 gradually increased until 3 h after UV, and decreased cleaved ANXA1 was detected 4 h after UV in HeLa cells. The decrease of ANXA1 cleavage may be due to the DDR of UV-damaged cells.26 To further validate whether HAUSP is related to the cleavage of ANXA1, we performed endogenous IP assay in HeLa cells. The binding affinity of HAUSP to ANXA1 in a time-dependent manner following UV showed a gradual increase, and it peaked at 3 h after UV coinciding with the maximum of the cleaved ANXA1 (Figure 4b). On the basis of our result, we decided to incubate cells for 3 h following UV for further experiments. Interestingly, immunofluorescence analysis targeting endogenous HAUSP and ANXA1 in HeLa cells showed nuclear foci formation of both HAUSP and ANXA1 in the nucleus upon UV-induced DNA damage (Figure 4c), suggesting that HAUSP is possibly involved in the ANXA1-mediated damage response in the nucleus. Therefore, we validated the knock-down effect of HAUSP on the damage response function of ANXA1 using HAUSP-specific siRNA (Figure 5a). Then, we investigated the endogenous ubiquitination level of ANXA1 following UV in the presence or absence of HAUSP. The result showed that HAUSP could reduce the ANXA1 ubiquitination level more upon UV, possibly due to the increase in HAUSP-ANXA1 binding. However, in HAUSP-depleted cells, the ANXA1 ubiquitination level did not show any difference following UV (Figure 5b), indicating that HAUSP might be a specific DUB for ANXA1. Next, using a lentiviral vector that contains a HAUSP-specific shRNA, we generated HAUSP knock-down HeLa cells (Figure 5c). The level of cleaved form for ANXA1 has changed in HAUSP-depleted HeLa cells compared with the level found in normal HeLa cells. However, overexpression of HAUSP had no effect on ANXA1 cleavage upon UV exposure (Figure 5d). In addition, depletion of HAUSP affected the localization of ANXA1 (Figure 5e). Unlike normal HeLa cells, showing co-localization of HAUSP and ANXA1 in the nucleus by forming nuclear foci in response to UV, the absence of HAUSP abrogated the nuclear localization of ANXA1. We also confirmed the escape of ANXA1 from the nucleus following UV in the absence of HAUSP but not in the presence of HAUSP by fraction assay (Figure 5f). Collectively, our data suggest that the deubiquitination of ANXA1 is specifically mediated by HAUSP, and HAUSP-mediated deubiquitination of ANXA1 may be important for ANXA1's damage response function in the nucleus upon UV. In addition, the failure of deubiquitination of ANXA1 leads to cleavage of ANXA1, resulting in externalization of ANXA1 from the nucleus.

Figure 4.

Figure 4

Open in a new tab

UV induces increased binding of HAUSP and ANXA1. (a) HeLa cells time-dependently treated with 30 mJ/cm2 of UV were lysed and ANXA1 protein levels were detected by western blotting. (b) HeLa cells described in (a) were lysed, and the interaction between HAUSP and ANXA1 was chased by immunoprecipitation using an anti-HAUSP antibody followed by western blotting using anti-HAUSP and anti-ANXA1 antibodies. PARP-1 antibody was used as a control for UV-induced damage. All statistical data are presented as a means (n=3, *P<0.05). (c) HeLa cells incubated for 3 h following UV were incubated with anti-HAUSP and anti-ANXA1 antibodies followed by FITC staining. DAPI was used for counterstaining of the nucleus (Green: ANXA1, Red: HAUSP, Blue: DAPI, and Yellow: co-localization). The data are representative of four biological replicates (n=4, *P<0.05)

Figure 5.

Figure 5

Open in a new tab

HAUSP knock-down effect on the regulation of ANXA1 following UV-induced DNA damage. (a) Two different HAUSP-specific siRNAs as described in Materials and methods were transfected into HeLa cells. The cells were harvested and lysed 72 h after incubation. The depleted HAUSP levels were detected by western blotting using an anti-HAUSP antibody. (b) HeLa cells transfected with siRNA specific for HAUSP or control siRNA were exposed to UV and incubated for 3 h. Then, cell lysates were immunoprecipitated with an anti-ANXA1 antibody. Subsequent western blotting was performed to detect the ubiquitination level of ANXA1 using an anti-ubiquitin antibody. (c) HAUSP-depleted (HAUSP KD) and control shRNA transduced (Control) HeLa cells were generated by lentiviral induction as described in Materials and methods. Depleted HAUSP levels compared with normal HeLa cells were detected by western blotting using an anti-HAUSP antibody. (d) HeLa, HAUSP knock-down HeLa (HAUSP KD), and HAUSP overexpressed HeLa cells either incubated for 3 h following UV treatment or not were blotted with anti-HAUSP and anti-ANXA1 antibodies to detect the cleavage of ANXA1 protein. (e) UV-treated or normal HeLa KD cells were immunostained using FITC staining after incubation with an anti-ANXA1 antibody. DAPI was used for counterstaining of the nucleus (Green: ANXA1, and Blue: DAPI). (f) Nucleus-cytosol fraction was performed using HeLa and HeLa KD cell lysates. Then, HAUSP and ANXA1 levels were detected using anti-HAUSP and anti-ANXA1 antibodies. Anti-PARP and anti-α-tubulin antibodies were used as fraction controls. Statistical data are presented as a means (n=3, *P<0.05)

Different roles of HAUSP by interacting with ANXA1 in Jurkat cells upon UV irradiation

It has previously been reported that ANXA1 itself can induce caspase-dependent apoptosis.19, 27, 28, 29 In addition, during secondary necrosis, the cleaved fragment of ANXA1 (Ac2-26) induces apoptotic cell clearance by recruiting macrophages.20 The study mainly evaluated ANXA1 cleavage, which is mediated by ADAM10 protease, during secondary necrosis using hematogenous cells including Jurkat cells, demonstrating that externalized Ac2-26 from apoptotic cells provokes macrophage activation for phagocytosis of dying cells. Therefore, we further validated the relevance of HAUSP with ANXA1 cleavage and subsequent functions in damaged cells using Jurkat cells. First, the binding between HAUSP and ANXA1 was confirmed via endogenous IP assay (Figures 6a and b). As expected, binding of HAUSP and ANXA1 was clearly detected. Intriguingly, their binding in Jurkat cells also time dependently increased 3 h after UV (Figure 6c). In addition, HAUSP had effect on the ubiquitination of ANXA1 in Jurkat cells (Supplementary Figures S6a and b). By generating HAUSP knock-down Jurkat cells (HAUSP KD) with a lentiviral shRNA for HAUSP (Figure 6d), we evaluated the importance of HAUSP in the regulation of ANXA1 upon UV-induced DNA damage. According to the results shown in HeLa cells, we considered the depletion of HAUSP to also affect ANXA1 cleavage in the Jurkat cells. However, the depletion of HAUSP reduced both the full-length and the cleaved form of ANXA1, contrary to increased cleavage of ANXA1 in HAUSP KD HeLa cells (Figure 6e). This unexpected result may be derived from multiple functions of ANXA1, which can be the main causes of different expression levels and roles of ANXA1 in different types of cancers.30, 31, 32, 33 Thus, we concluded that the failure of deubiquitination of ANXA1 by the depletion of HAUSP leads to reduced stability and cleavage of ANXA1 in the case of Jurkat cells, indicating that HAUSP is a positive regulator for ANXA1 in Jurkat cells. Using normal, control shRNA-transduced (control), and HAUSP KD Jurkat cells, we further evaluated the knock-down effect of HAUSP on apoptosis or necrosis level following UV. A previous study reported that the inhibition of the deubiquitinating activity of HAUSP using a small molecule that specifically inhibits HAUSP resulted in apoptosis in multiple myeloma (MM).34 We also detected increased late apoptotic/necrotic level in HAUSP KD Jurkat cells even in the absence of UV (Figure 6f). However, the ratio of the increase of late apoptotic/necrotic cell level following UV resulted in the lowest levels in HAUSP KD cells (Figure 6f; Supplementary Figure S7), suggesting that reduction of ANXA1 cleavage cannot increase apoptosis even after UV when HAUSP is depleted. Finally, we checked the transmigration of THP-1 monocytes toward cell supernatants derived from UV-treated normal, control, and HAUSP KD Jurkat cells. As expected, the transmigrative ratio of monocytes is the weakest in HAUSP-depleted cell supernatants (Figure 6g). Chemokines that attract migration of macrophage include various factors including Ac2-26. Thus, basal levels of transmigration ratio are shown even in HAUSP-depleted cells, and cell supernatants containing Ac2-26 showed increased transmigrative ratio. Overall, our findings demonstrate that depletion of HAUSP can decrease ANXA1 stability and cleavage of ANXA1, thereby reducing not only cell apoptosis upon UV but also transmigration of macrophages mediated by Ac2-26. These data suggest that deubiquitination of ANXA1 by HAUSP is essential for the UV-induced damage response function of ANXA1 in Jurkat cells.

Figure 6.

Figure 6

Open in a new tab

The role of interaction between HAUSP and ANXA1 following UV in Jurkat cells. (a, b) Endogenous binding of HAUSP and ANXA1 is confirmed by endogenous immunoprecipitation analysis. Jurkat cell lysates were immunoprecipitated with an anti-HAUSP or an anti-ANXA1 antibody. Then, western blotting was performed to detect ANXA1 or HAUSP expression using the respective antibodies. (c) Jurkat cells, time dependently incubated with 30 mJ/cm2 UV treatment, were lysed and immunoprecipitated with an anti-HAUSP antibody. Then, ANXA1 levels were detected by western blotting using an anti-ANXA1 antibody. (d) HAUSP-depleted (HAUSP KD) and control shRNA transduced (Control) Jurkat cells were generated as shown in Figure 4c. Depletion of HAUSP compared with normal Jurkat cells was detected by western blotting using an anti-HAUSP antibody. (e) Normal, control shRNA transduced (Control), and HAUSP-depleted Jurkat cells (HAUSP KD) were exposed to UV followed by incubation for 4 h. Then, cell lysates were immunoprecipitated with an anti-HAUSP antibody. Subsequent western blotting was performed with indicated antibodies. (f) Cells were stained with Annexin V-FITC/PI for verifying the apoptotic or necrotic cell ratio. (g) Jurkat, control, and HAUSP KD Jurkat cells were exposed to UV and incubated for 3 h. Then, cell supernatants were harvested and placed into the lower chamber. Subsequently, THP-1 monocytes cultured in serum-free media were placed into the upper chamber and incubated with respective cell supernatants in addition to Ac2-26 containing media. The transmigration ratio was detected as described in Materials and Methods. Each value represents the mean (±S.D.) of a representative of three independent experiments, and an asterisk mark (*) means statistical significance

Discussion

Numerous studies have demonstrated that the expression patterns of ANXA1 in cancers vary. For example, downregulated expression of ANXA1 is shown in thyroid cancer, prostate cancer, head and neck cancer, esophageal cancer, hairy cell leukemia (HCL), and B-cell non-Hodgkin's lymphomas.35, 36, 37, 38, 39, 40 However, it is also reported that ANXA1 is overexpressed in hepatocarcinoma and pancreatic cancer.41, 42 Moreover, in breast cancer, the expression of ANXA1 may be dependent on specific subtypes. de Graauw et al.43 validated the mRNA levels of ANXA1 in both luminal- and basal-like breast cancer cells, and the results showed upregulated mRNA levels of ANXA1 in basal-like breast cancer cells whereas luminal-like breast cancer cells showed reduced mRNA levels of ANXA1.43 These different expression patterns of ANXA1 highlight that ANXA1 may be regulated by different mechanisms. Indeed, it is well known that ANXA1 is regulated via various posttranslational modifications. Ubiquitination of ANXA1 mediated by E6-associated protein (E6AP) has been reported previously.25 We could also demonstrate ubiquitination and deubiquitination of ANXA1 (Figures 3a and b). HAUSP reduced the level of ANXA1; however, a catalytically inactive mutant of HAUSP (C223S) has less effect on the ANXA1 ubiquitination (Figure 3b), which is different from the fully denatured condition (Figure 3d). Because the non-catalytic function of DUBs was reported,44 it is presumed that the catalytic inactive mutant of HAUSP also has effect on ANXA1 ubiquitination through the interaction of other DUBs or E3 ligases in vivo, and further biochemical studies to understand this subtlety are required. In addition to ubiquitination, two recent different studies have investigated the modification of ANXA1 through small ubiquitin-like modifiers (SUMO) in a mouse model.45, 46 In particular, it showed that mammalian ANXA1 has the consensus motif 160LKRD for SUMOylation, suggesting that human ANXA1 can also be modified by SUMO. 46 Because SUMOylation can affect protein-protein interaction or protein localization,47 it is also possible that SUMOylated ANXA1 may have altered localizations or functions. The alterative localization of ANXA1 by post-translational modification is demonstrated by Solito et al.48 They found the translocation of cytosolic ANXA1 to the cell surface via phosphorylation at serine-27 in lipopolysaccharide (LPS)-treated cells. In this regard, our result of immunofluorescence analysis in HAUSP KD HeLa cells, which showed translocation of nuclear ANXA1 to the cytosol (Figure 5e), may be due to the failure of deubiquitination of ANXA1 mediated by HAUSP.

Nuclear localization of ANXA1 has been broadly studied for several years. Over 50% of oral squamous cell carcinoma (OSCC) showed nuclear localization of ANXA1,49 suggesting that nuclear ANXA1 can be a prognostic factor in OSCC. Na et al. suggested the role of ANXA1 in cellular stress condition.18 They showed that ANXA1 is located in the nucleus by the induction of stress reagents including heat, oxidative stress, and a sulfhydryl-reactive agent. Heat-shock damage also caused nuclear translocation of ANXA1 in MCF7 breast cancer cells, resulting in protection of cancer cells from the damage via unknown mechanism.50 Finally, Yan et al.22 analyzed ANXA1 as one of nuclear proteins of BaP-treated HeLa cells by using the 2-DE method. They suggested that ANXA1 may have a protective role in BaP-induced damage response. We also showed nuclear ANXA1 in HeLa cells (Figure 2e). Interestingly, we could detect nuclear localization of ANXA1 forming nuclear foci together with HAUSP when UV was inflicted on HeLa cells (Figure 4c). It is noteworthy that UV induces nuclear foci formation, leading to the induction of DDR.51, 52 Thus, our data for the failure of foci formation of ANXA1 in HAUSP-depleted HeLa cells (Figure 5e) indicate that HAUSP may be required for the DDR function of ANXA1 following UV-induced DNA damage in certain types of cells (Figure 7a).

Figure 7.

Figure 7

Open in a new tab

A schematic model for UV damage response by the interaction between HAUSP and ANXA1. (a) UV damage response of HAUSP-ANXA1 in HeLa cells. HAUSP deubiquitinates ANXA1 and protects ANXA1 from the proteasomal degradation and protease-mediated cleavage, leading to stress response function of ANXA1 upon UV damage. (b) UV damage response of HAUSP-ANXA1 in Jurkat cells. HAUSP mediates ANXA1 cleavage, leading to dying cell clearance function of ANXA1 upon UV damage

It is notable that, in contrast to HeLa cells, reduced full-length and cleavage of ANXA1 in HAUSP knockdown condition was detected in Jurkat cells (Figure 6e). As previously reported, overexpression of ANXA1 can lead to cell apoptosis.19, 27, 28, 29 Our result also demonstrated that reduced ANXA1 by the absence of HAUSP shows reduced apoptotic level after exposure to UV (Figure 6f). The cleavage of ANXA1 is well established in immune regulation. Blume et al.20 demonstrated that ADAM10 specifically cleaved ANXA1, and Ac2-26 provided a ‘find-me' signal to monocytes for dying cell clearance, functioning as a chemokine. Although there are various chemotaxic components, our data showed that even the absence of only Ac2-26, resulting from HAUSP depletion, could reduce the transmigration of THP-1 monocytes toward dying cells (Figure 6g), indicating that HAUSP is partially related to the dying cell clearance through the regulation of ANXA1 cleavage (Figure 7b).

In conclusion, we showed a line of evidence that ANXA1 is regulated by the deubiquitinating activity of HAUSP, and the following results vary depending on cell types. Altered binding affinity toward HAUSP, localization, and functional cleavage of ANXA1 were shown in the absence of HAUSP following UV. In this regard, we suggest that deubiquitination of ANXA1 by HAUSP is essential for UV-induced damage responsive function of ANXA1. To evaluate the relevance of HAUSP-ANXA1 interaction with damage response function as shown in our results of HeLa cells, further mechanism studies of signaling pathway should be validated. Similarly, it would be of interest to establish the details underlining the deubiquitination and cleavage of ANXA1 in the resolution of the immune system to provide insights into the molecular regulation of ANXA1 by HAUSP.

Materials and Methods

Cell culture and UV induction

HeLa, human embryonic kidney (HEK) 293T, and 293FT cells were grown in Dulbercco's modified Eagle's medium (DMEM, Gibco, Grand Island, NY, USA) supplemented with 10% FBS, 1% penicillin/streptomycin (Gibco). Jurkat T and THP-1 cells were grown in RPMI-1640 medium supplemented with 10% FBS, 1% penicillin/streptomycin (Gibco). Cells were grown at 37 °C in 5% CO2 atmosphere. To evaluate damage response mediated by UV, cells were UV irradiated with 30 mJ/cm2 in the UV cross-linker (CL-1000 UV crosslinker, UVP, CA, USA) for the indicated time.

Expression constructs and antibodies

A full-length cDNA for human HAUSP, ANXA1, PKM2, and PP2A was PCR amplified from HeLa and subcloned into the Flag, Myc, and GST epitope encoded vectors, respectively. Following antibodies were used for western blotting or IP: anti-Myc (9E10, Hybridoma cell media), anti-HA (1:200, 12CA5 hybridoma cell media), anti-Flag (1:5000 Sigma-Aldrich, St. Louis, MO, USA), anti-HAUSP (1:1000, Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-ANXA1 (1:1000, BD Bioscience, San Jose, CA, USA or 1:000, Young In Frontier, Seoul, South Korea), anti-PARP1 (1:1000, Santa Cruz Biotechnology), anti-β-actin (1:3000, Santa Cruz Biotechnology), anti-α-tubulin (1:1000, Santa Cruz Biotechnology) and anti-ubiquitin (1:1000, Santa Cruz Biotechnology) antibody.

Site-direct mutagenesis

A catalytic mutant of HAUSP (C223S) and ANXA1 mutants (S5A, S182A, S5A/S182A) were generated by site-direct mutagenesis. The following primer sequences were used for generating mutants: ANXA1 (S5A); forward, 5′-ATG GCA ATG GTA GCA GAA TTC CTC A-3′, reverse, 5′-TGA GGA ATT CTG CTA CCA TTG CCA T-3′, ANXA1 (S182A); forward, 5′-CGG AAC GCT TTG CTT GCT CTT GCT AAG GGT G-3′, reverse, 5′-CAC CCT TAG CAA GAG CAA GCA AAG CGT TCC G-3′. ANXA1 mutant (S5A/S182A) was generated using ANXA1 (S5A) as a template and ANXA1 (S182A) primer. After PCR and gel purification, Dpn I (Enzynomics, Daejeon, Korea) enzyme was added.

RNAi interference and knock-down cell lines using lentiviral vectors

siRNAs for HAUSP were generated with following sequences: #1; 5'-CAU GCA CAA GCA GUG CUG AAG AUA A-3', #2 5′-AAA GU U UCC CAC CCA AAU GAC UUU G-3′ (Ambion, Austin, TX, USA). In all, 20 nM of HAUSP siRNA was introduced into the cells by transfection using Opti-MEM and RNAimax (Invitrogen, Paisly, UK) according to the manufacturer's instructions. For the generation of stably HAUSP-depleted, HAUSP knock-down cells (HAUSP KD) or control shRNA transduced cells (Control), lentiviral shRNAs with packaging DNA vectors were transfected into HEK 293FT cells using Lipofectamine 2000 (Invitrogen). Forty-eight hours after transfection, the cell supernatants were filtrated. Then, the lentivirus contained in the supernatants was transduced into HeLa or Jurkat cells together with polybrene (Sigma-Aldrich). Finally, puromycin (Sigma-Aldrich) for the selection of shRNA-transduced cells was used during cell culture.

Western blotting, IP, GST-pull down assay, ubiquitination, and deubiquitination assays

For western blotting, IP, ubiquitination, and deubiquitination assays, cells were lysed in a lysis buffer (150 mM NaCl, 50 mM Tris-HCl (pH 7.4), 1 mM PMSF, 1 mM DTT, 1% NP-40 and protease inhibitor cocktail (PIC) (Roche, Mannheim, Germany)). After resuspension of cells, samples were incubated for 20 min on ice and centrifuged at 13 000 r.p.m. for 15 min. Then, proteins were loaded onto 10% SDS-PAGE gel and transfered onto polyvinylidene fluoride (PVDF) microporous membranes (Millipore, Billerica, MA, USA). Membranes were blocked with 5% skim milk in TBST (20 mM Tris-HCl (pH 7.5), 150 mM NaCl) for 1 h and incubated with primary antibodies at 4 °C overnight. The membranes were incubated with secondary antibodies followed by detection using the ECL reagent solution (Young In Frontier). Membranes were stripped with stripping buffer (Amresco, Solon, OH, USA) according to the manufacture's protocol. For co-IP assay, cell lysates were incubated with indicated antibodies for 4 h at 4 °C. Then, protein A/G PLUS agarose beads (Santa Cruz Biotechnology) were added and rotated for 1 h. The precipitated protein complexes were blotted by western blotting. GST-pull down assay was performed as previously described.53 Ubiquitination and deubiquitination assays were performed using HA-tagged ubiquitin-transfected cell lysates. After IP with an anti-HA antibody, protein samples were analyzed by western blotting. Ubiquitination bands were detected using an anti-HA antibody. Western blotting images were analyzed with Image J program (National Institutes of Health (NIH), Bethesda, MD, USA).

His-tagged protein purification with Ni-NTA beads

HEK 293T cells transfected with His-tagged ubiquitn were lysed with urea lysis buffer (8 M urea, 100 mM NaPO4 (pH 8.0), 15 mM imidazole). After sonication, the samples were incubated at room temperature and centrifuged for 20 min at 14 000 r.p.m. at 10 °C. Cell extracts were incubated with Ni-NTA beads (Novagen, Madison, WI, USA) at room temperature. Beads were washed with washing buffer (6 M GuHCl, 0.1% Triton X-100, 100 mM NaPO4 (pH 8.0), 15 mM imidazole) two times, and once with urea lysis buffer containing 0.1% Triton X-100, and finally washed with urea lysis buffer. For protein elution, beads were eluted with elution buffer (8 M urea, 100 mM NaPO4 (pH 8.0), 100 mM imidazole) for 5 min at room temperature.

Immunofluorescence analysis

HeLa and Jurkat T cells (5 × 103 or 1 × 104 per 12 mm flame sterilized coverslips) treated with UV (30 mJ/cm2) or without were washed with 1 × PBS and fixed with 5% formaldehyde (Sigma-Aldrich) for 10 min at room temperature. Then, cells were rinsed three times with 0.1% Triton X-100/PBS, and blocked with 3% skim milk in 0.1% Triton X-100/PBS for 1 h at room temperature. The cells were incubated with anti-HAUSP and/or anti-ANXA1 antibodies for 2 h at room temperature. After, the cells were washed three times with 0.1% Triton X-100/PBS, and then incubated with 1:200 diluted FITC-conjugated goat anti-rabbit or anti-mouse IgG (Molecular Probes, Eugene, OR, USA). Cells were stained with 4', 6-diamindino-2-phenylindole (DAPI) (Molecular Probes) for nuclei staining. Afterward, coverslips were mounted onto glass slides using 90% glycerol/100 mM Tris (pH 8.0) and cell images were captured by using a Zeiss Axiovert 100 M microscope (Carl Zeiss, Oberkochen, Germany) attached to an LSM 510 confocal unit.

Fraction assay

For the nucleus and cytosol fraction, resuspension buffer (10 mM HEPES, 10 mM KCl, 1.5 M MgCl2, and protease inhibitor cocktail) with 0.1% of NP-40 was used. Fifteen minutes after ice incubation, cell lysates were centrifugated at 14 000 r.p.m. for 2 min at 4 °C. The supernatants were for cytosolic fraction, and the pellet was washed with resuspension buffer without NP-40. Then, TNN buffer (50 mM Tris, 250 mM NaCl, 5 mM EDTA, and protease inhibitor cocktail) with 0.5% of NP-40 was used for pellet resuspesion. After incubation on ice for 1 h, samples were homogenized with 1 ml syringe and centrifugated at 16 000 r.p.m. at 4 °C for 40 min. Finally, the supernatants were used as nuclear fraction.

Flow cytometry

Flow cytometry was performed with a FACS Calibur (BD Bioscience) and CellQuest analysis software. Apoptosis was determined by staining with Annexin V-FITC/propidium iodide (PI) (BD BioScience) double staining according to the manufacturer's instructions. Briefly, cells (2 × 106) were washed with cold PBS and then resuspended in binding buffer (10 mM Hepes/NaOH (pH 7.4), 0.14 M NaCl, 2.5 mM CaCl2), and FITC Annexin V and PI were added. After incubation at room temperature for 15 min in the dark, flow cytometry was analyzed. Annexin V-FITC and PI double staining were regarded as late apoptotic or necrotic cells.

Transmigration assay

Transmigration assay was performed using the QCM Chemotaxis migration assay kit (Millipore) according to the manufacturer's instruction. Briefly, THP-1 (1 × 105) cells were incubated in the upperside of membranes, and bottom wells were filled with cell-culture supernatants or medium or the N-terminal fragment of ANXA1 (Ac2-26). Ten hours after incubation, cells were lysed with a lysis buffer with the CyQuant GR dye. Then, fluorescence was detected using 480/520 filter set. The percentage of THP-1 monocyte migration was calculated by regarding serum containing normal cell supernatants as a hundred percent.

2-DE and MALDI-TOF/MS analyses

Aliquots in sample buffer (7 M urea, 2 M thiourea, 4.5% CHAPS, 100 mM DTE, 40 mM Tris, pH 8.8) were applied to immobilized pH 3–10 non-linear gradient strips (Amersham Biosciences, Uppsala, Sweden). IEF was performed at 80 000 Vh. The second dimension was analyzed on 9–16% linear gradient polyacrylamide gels (18 cm 6 20 cm 6 1.5 mm) at constant 40 mA per gel for approximately 5 h. After protein fixation in 40% methanol and 5% phosphoric acid for 1 h, the gels were stained with CBB G-250 for 12 h. The gels were destained with H2O, scanned in a Bio-Rad GS710 densitometer (Richmond, CA, USA) and converted into electronic files, which were then analyzed with Image Master Platinum 5.0 image analysis program (Amersham Biosciences). Spots were considered to be reproducibly present in all 2-DE gels, which samples were prepared from three independent HAUSP-overexpressing cell extracts.

For MALDI-TOF/MS analysis, the peptides were concentrated by a POROS R2, Oligo R3 column (Applied Biosystems, Foster City, CA, USA). After washing the column with 70% acetonitrile, 100% acetonitrile and then 50 mM ammonium bicarbonate, samples were applied to the R2, R3 column and eluted with cyano-4-hydroxycinamic acid (CHCA) (Sigma) dissolved in 70% acetonitrile and 2% formic acid onto the MALDI plate (Opti-TOFTM 384-well Insert, Applied Biosystems). MALDI-TOF/MS was performed on 4800 MALDI-TOF/TOF Analyzer (Applied Biosystems) equipped with a 355-nm Nd:YAG laser. The pressure in the TOF analyzer is approximately 7.6e-07 Torr. The mass spectra were obtained in the reflection mode with an accelerating voltage of 20 kV and sum from either 500 laser pulses and calibrated using the 4700 calibration mixture (Applied Biosystems). NCBInr database (downloaded on Mar 242,013, # of entries=695 124 sequence) searching was performed with the MASCOT search engine (http://www.matrixscience.com). The peak list-generating software Data explorer version 4.4 (PerSeptiveBiosystems, Framingham, MA, USA) was used. Database search criteria were taxonomy, Homo sapiens, fixed modification; carboxyamidomethylated (+57) at cysteine residue; variable modification; oxidized (+16) at methionine residues, maximum allowed missed cleavage, 1, MS tolerance, 100 ppm. Only peptides resulting from trypsin digests were considered, and trypsin peak (842.5090, 2211.1040) was used for internal calibration.

Acknowledgments

We would like to thank to Dr Seung-Hyuk Seok at Seoul National University for kind donation of N-terminal fragment of ANXA1 protein and Dr Suresh Ramakrishna for his kind critical comments on the manuscript. This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2013-0141).

Glossary

DDR

DNA damage response

DUBs

deubiquitinating enzymes

E6AP

E6-associated protein

HCL

hairy cell leukemia

JAMM

JAB1/MPN/Mov34 metalloenzyme

MCPIPs

monocyte chemotactic protein-induced proteases

MM

multiple myeloma

MJDs

Machado-Josephin domain papain-like cysteine proteases

OSCC

oral squamous cell carcinoma

OUT

ovarian tumor

SUMO

small ubiquitin-like modifiers

UCHs

ubiquitin C-terminal hydrolases

UPP

ubiquitin-proteasome pathway

USPs

ubiquitin-specific proteases

The authors declare no conflict of interest.

Footnotes

Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)

Edited by Y Haupt

Supplementary Material

Supplementary Figure legends
Click here for additional data file. (29.5KB, doc)
Supplementary Figures
Click here for additional data file. (2.9MB, ppt)

References

  1. 1Ivanov SS, Roy CR. Modulation of ubiquitin dynamics and suppression of DALIS formation by the Legionella pneumophila Dot/Icm system. Cell Microbiol 2009; 11: 261–278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. 2Lim KH, Baek KH. Deubiquitinating enzymes as therapeutic targets in cancer. Curr Pharm Des 2013; 19: 4039–4052. [DOI] [PubMed] [Google Scholar]
  3. 3Bhattacharya S, Ghosh MK. Cell death and deubiquitinases: perspectives in cancer. Biomed Res Int 2014; 2014: 435197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. 4Baek KH. Conjugation and deconjugation of ubiquitin regulating the destiny of proteins. Exp Mol Med 2003; 35: 1–7. [DOI] [PubMed] [Google Scholar]
  5. 5Ernst A, Avvakumov G, Tong J, Fan Y, Zhao Y, Alberts P et al. A strategy for modulation of enzymes in the ubiquitin system. Science 2013; 339: 590–595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. 6Sowa ME, Bennett EJ, Gygi SP, Harper JW. Defining the human deubiquitinating enzyme interaction landscape. Cell 2009; 138: 389–403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. 7Komander D, Clague MJ, Urbe S. Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol 2009; 10: 550–563. [DOI] [PubMed] [Google Scholar]
  8. 8Sheng Y, Saridakis V, Sarkari F, Duan S, Wu T, Arrowsmith CH et al. Molecular recognition of p53 and MDM2 by USP7/HAUSP. Nat Struct Mol Biol 2006; 13: 285–291. [DOI] [PubMed] [Google Scholar]
  9. 9Li M, Chen D, Shiloh A, Luo J, Nikolaev AY, Qin J et al. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 2002; 416: 648–653. [DOI] [PubMed] [Google Scholar]
  10. 10Khoronenkova SV, Dianova II, Ternette N, Kessler BM, Parsons JL, Dianov GL. ATM-dependent downregulation of USP7/HAUSP by PPM1G activates p53 response to DNA damage. Mol Cell 2012; 45: 801–813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. 11Rosengarth A, Gerke V, Luecke H. X-ray structure of full-length annexin 1 and implications for membrane aggregation. J Mol Biol 2001; 306: 489–498. [DOI] [PubMed] [Google Scholar]
  12. 12Gerke V, Moss SE. Annexins: from structure to function. Physiol Rev 2002; 82: 331–371. [DOI] [PubMed] [Google Scholar]
  13. 13Gerke V, Creutz CE, Moss SE. Annexins: linking Ca2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol 2005; 6: 449–461. [DOI] [PubMed] [Google Scholar]
  14. 14Perretti M, D'Acquisto F. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat Rev Immunol 2009; 9: 62–70. [DOI] [PubMed] [Google Scholar]
  15. 15Vago JP, Nogueira CR, Tavares LP, Soriani FM, Lopes F, Russo RC et al. Annexin A1 modulates natural and glucocorticoid-induced resolution of inflammation by enhancing neutrophil apoptosis. J Leukoc Biol 2012; 92: 249–258. [DOI] [PubMed] [Google Scholar]
  16. 16Paweletz CP, Ornstein DK, Roth MJ, Bichsel VE, Gillespie JW, Calvert VS et al. Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res 2000; 60: 6293–6297. [PubMed] [Google Scholar]
  17. 17Swa HL, Blackstock WP, Lim LH, Gunaratne J. Quantitative proteomics profiling of murine mammary gland cells unravels impact of annexin-1 on DNA damage response, cell adhesion, and migration. Mol Cell Proteomics 2012; 11: 381–393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. 18Rhee HJ, Kim GY, Huh JW, Kim SW, Na DS. Annexin I is a stress protein induced by heat, oxidative stress and a sulfhydryl-reactive agent. Eur J Biochem 2000; 267: 3220–3225. [DOI] [PubMed] [Google Scholar]
  19. 19Hsiang CH, Tunoda T, Whang YE, Tyson DR, Ornstein DK. The impact of altered annexin I protein levels on apoptosis and signal transduction pathways in prostate cancer cells. Prostate 2006; 66: 1413–1424. [DOI] [PubMed] [Google Scholar]
  20. 20Blume KE, Soeroes S, Keppeler H, Stevanovic S, Kretschmer D, Rautenberg M et al. Cleavage of annexin A1 by ADAM10 during secondary necrosis generates a monocytic "find-me" signal. J Immunol 2012; 188: 135–145. [DOI] [PubMed] [Google Scholar]
  21. 21Kim YS, Ko J, Kim IS, Jang SW, Sung HJ, Lee HJ et al. PKCdelta-dependent cleavage and nuclear translocation of annexin A1 by phorbol 12-myristate 13-acetate. Eur J Biochem 2003; 270: 4089–4094. [DOI] [PubMed] [Google Scholar]
  22. 22Yan C, Chen Z, Li H, Zhang G, Li F, Duerksen-Hughes PJ et al. Nuclear proteome analysis of benzo(a)pyrene-treated HeLa cells. Mutat Res 2012; 731: 75–84. [DOI] [PubMed] [Google Scholar]
  23. 23Yoo KJ, Lee HJ, Lee H, Lee KY, Lee SH, Chung HM et al. Expression and functional analyses of mHAUSP regulating apoptosis of cervical adenocarcinoma cells. Int J Oncol 2005; 27: 97–104. [PubMed] [Google Scholar]
  24. 24Lee HJ, Kim MS, Kim YK, Oh YK, Baek KH. HAUSP a deubiquitinating enzyme for p53, is polyubiquitinated, polyneddylated, and dimerized. FEBS Lett 2005; 579: 4867–4872. [DOI] [PubMed] [Google Scholar]
  25. 25Shimoji T, Murakami K, Sugiyama Y, Matsuda M, Inubushi S, Nasu J et al. Identification of annexin A1 as a novel substrate for E6AP-mediated ubiquitylation. J Cell Biochem 2009; 106: 1123–1135. [DOI] [PubMed] [Google Scholar]
  26. 26Latonen L, Laiho M. Cellular UV damage responses—functions of tumor suppressor p53. Biochim Biophys Acta 2005; 1755: 71–89. [DOI] [PubMed] [Google Scholar]
  27. 27Solito E, de Coupade C, Canaider S, Goulding NJ, Perretti M. Transfection of annexin 1 in monocytic cells produces a high degree of spontaneous and stimulated apoptosis associated with caspase-3 activation. Br J Pharmacol 2001; 133: 217–228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. 28Debret R, El Btaouri H, Duca L, Rahman I, Radke S, Haye B et al. Annexin A1 processing is associated with caspase-dependent apoptosis in BZR cells. FEBS Lett 2003; 546: 195–202. [DOI] [PubMed] [Google Scholar]
  29. 29Petrella A, Festa M, Ercolino SF, Zerilli M, Stassi G, Solito E et al. Induction of annexin-1 during TRAIL-induced apoptosis in thyroid carcinoma cells. Cell Death Differ 2005; 12: 1358–1360. [DOI] [PubMed] [Google Scholar]
  30. 30Wang KL, Wu TT, Resetkova E, Wang H, Correa AM, Hofstetter WL et al. Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Clin Cancer Res 2006; 12: 4598–4604. [DOI] [PubMed] [Google Scholar]
  31. 31Shen D, Nooraie F, Elshimali Y, Lonsberry V, He J, Bose S et al. Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis. Hum Pathol 2006; 37: 1583–1591. [DOI] [PubMed] [Google Scholar]
  32. 32Wang LD, Yang YH, Liu Y, Song HT, Zhang LY, Li PL. Decreased expression of annexin A1 during the progression of cervical neoplasia. J Int Med Res 2008; 36: 665–672. [DOI] [PubMed] [Google Scholar]
  33. 33Alves VA, Nonogaki S, Cury PM, Wunsch-Filho V, de Carvalho MB, Michaluart-Junior P et al. Annexin A1 subcellular expression in laryngeal squamous cell carcinoma. Histopathology 2008; 53: 715–727. [DOI] [PubMed] [Google Scholar]
  34. 34Chauhan D, Tian Z, Nicholson B, Kumar KG, Zhou B, Carrasco R et al. A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance. Cancer Cell 2012; 22: 345–358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. 35Petrella A, Festa M, Ercolino SF, Zerilli M, Stassi G, Solito E et al. Annexin-1 downregulation in thyroid cancer correlates to the degree of tumor differentiation. Cancer Biol Ther 2006; 5: 643–647. [DOI] [PubMed] [Google Scholar]
  36. 36Xin W, Rhodes DR, Ingold C, Chinnaiyan AM, Rubin MA. Dysregulation of the annexin family protein family is associated with prostate cancer progression. Am J Pathol 2003; 162: 255–261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. 37Garcia Pedrero JM, Fernandez MP, Morgan RO, Herrero Zapatero A, Gonzalez MV, Suarez Nieto C et al. Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status. Am J Pathol 2004; 164: 73–79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. 38Hu N, Flaig MJ, Su H, Shou JZ, Roth MJ, Li WJ et al. Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma. Clin Cancer Res 2004; 10: 6013–6022. [DOI] [PubMed] [Google Scholar]
  39. 39Falini B, Tiacci E, Liso A, Basso K, Sabattini E, Pacini R et al. Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1). Lancet 2004; 363: 1869–1870. [DOI] [PubMed] [Google Scholar]
  40. 40Vishwanatha JK, Salazar E, Gopalakrishnan VK. Absence of annexin I expression in B-cell non-Hodgkin's lymphomas and cell lines. BMC Cancer 2004; 4: 8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. 41de Coupade C, Gillet R, Bennoun M, Briand P, Russo-Marie F, Solito E. Annexin 1 expression and phosphorylation are upregulated during liver regeneration and transformation in antithrombin III SV40 T large antigen transgenic mice. Hepatology 2000; 31: 371–380. [DOI] [PubMed] [Google Scholar]
  42. 42Bai XF, Ni XG, Zhao P, Liu SM, Wang HX, Guo B et al. Overexpression of annexin 1 in pancreatic cancer and its clinical significance. World J Gastroenterol 2004; 10: 1466–1470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. 43de Graauw M, van Miltenburg MH, Schmidt MK, Pont C, Lalai R, Kartopawiro J et al. Annexin A1 regulates TGF-beta signaling and promotes metastasis formation of basal-like breast cancer cells. Proc Natl Acad Sci USA 2010; 107: 6340–6345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. 44Hanna J, Hathaway NA, Tone Y, Crosas B, Elsasser S, Kirkpatrick DS et al. Deubiquitinating enzyme Ubp6 functions noncatalytically to delay proteasomal degradation. Cell 2006; 127: 99–111. [DOI] [PubMed] [Google Scholar]
  45. 45Caron D, Maaroufi H, Michaud S, Tanguay RM, Faure RL. Annexin A1 is regulated by domains cross-talk through post-translational phosphorylation and SUMOYlation. Cell Signal 2013; 25: 1962–1969. [DOI] [PubMed] [Google Scholar]
  46. 46Hirata F, Thibodeau LM, Hirata A. Ubiquitination and SUMOylation of annexin A1 and helicase activity. Biochim Biophys Acta 2010; 1800: 899–905. [DOI] [PubMed] [Google Scholar]
  47. 47Hilgarth RS, Murphy LA, Skaggs HS, Wilkerson DC, Xing H, Sarge KD. Regulation and function of SUMO modification. J Biol Chem 2004; 279: 53899–53902. [DOI] [PubMed] [Google Scholar]
  48. 48Solito E, Christian HC, Festa M, Mulla A, Tierney T, Flower RJ et al. Post-translational modification plays an essential role in the translocation of annexin A1 from the cytoplasm to the cell surface. FASEB J 2006; 20: 1498–1500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. 49Lin CY, Jeng YM, Chou HY, Hsu HC, Yuan RH, Chiang CP et al. Nuclear localization of annexin A1 is a prognostic factor in oral squamous cell carcinoma. J Surg Oncol 2008; 97: 544–550. [DOI] [PubMed] [Google Scholar]
  50. 50Nair S, Hande MP, Lim LH. Annexin-1 protects MCF7 breast cancer cells against heat-induced growth arrest and DNA damage. Cancer Lett 2010; 294: 111–117. [DOI] [PubMed] [Google Scholar]
  51. 51Park MS, Knauf JA, Pendergrass SH, Coulon CH, Strniste GF, Marrone BL et al. Ultraviolet-induced movement of the human DNA repair protein, Xeroderma pigmentosum type G, in the nucleus. Proc Natl Acad Sci USA 1996; 93: 8368–8373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. 52Polo SE, Jackson SP. Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications. Genes Dev 2011; 25: 409–433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. 53Suresh B, Ramakrishna S, Kim YS, Kim SM, Kim MS, Baek KH. Stability and function of mammalian lethal giant larvae-1 oncoprotein are regulated by the scaffolding protein RanBPM. J Biol Chem 2010; 285: 35340–35349. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Figure legends
Click here for additional data file. (29.5KB, doc)
Supplementary Figures
Click here for additional data file. (2.9MB, ppt)

Articles from Cell Death & Disease are provided here courtesy of Nature Publishing Group

RESOURCES